News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
571,000 Results
Type
Article (29121)
Company Profile (190)
Press Release (541689)
Multimedia
Podcasts (36)
Webinars (8)
Section
Business (161430)
Career Advice (1489)
Deals (28498)
Drug Delivery (70)
Drug Development (80449)
Employer Resources (95)
FDA (14074)
Job Trends (12306)
News (286607)
Policy (25348)
Tag
Academia (2098)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (84)
Alliances (44301)
ALS (93)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (125)
Approvals (14078)
Artificial intelligence (258)
Autoimmune disease (20)
Automation (15)
Bankruptcy (207)
Best Places to Work (10437)
BIOSECURE Act (14)
Biosimilars (75)
Biotechnology (133)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2234)
Cardiovascular disease (174)
Career advice (1256)
Career pathing (25)
CAR-T (154)
Cell therapy (417)
Cervical cancer (20)
Clinical research (66486)
Collaboration (786)
Compensation (490)
Complete response letters (22)
COVID-19 (2279)
CRISPR (37)
C-suite (227)
Cystic fibrosis (93)
Data (2200)
Decentralized trials (2)
Denatured (16)
Depression (47)
Diabetes (241)
Diagnostics (5968)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (27)
Drug discovery (114)
Drug pricing (79)
Drug shortages (14)
Duchenne muscular dystrophy (85)
Earnings (60127)
Editorial (28)
Employer branding (10)
Employer resources (83)
Events (88072)
Executive appointments (689)
FDA (15314)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (720)
Gene editing (97)
Generative AI (24)
Gene therapy (290)
GLP-1 (582)
Government (3704)
Grass and pollen (5)
Guidances (60)
Healthcare (17342)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (110)
Indications (29)
Infectious disease (2408)
Inflammatory bowel disease (143)
Inflation Reduction Act (6)
Influenza (49)
Intellectual property (89)
Interviews (225)
IPO (13754)
IRA (35)
Job creations (2267)
Job search strategy (1113)
Kidney cancer (11)
Labor market (26)
Layoffs (354)
Leadership (14)
Legal (4379)
Liver cancer (67)
Lung cancer (320)
Lymphoma (147)
Machine learning (6)
Management (27)
Manufacturing (251)
MASH (63)
Medical device (11496)
Medtech (11499)
Mergers & acquisitions (15319)
Metabolic disorders (581)
Multiple sclerosis (76)
NASH (14)
Neurodegenerative disease (98)
Neuropsychiatric disorders (22)
Neuroscience (1930)
NextGen: Class of 2025 (5709)
Non-profit (3920)
Now hiring (21)
Obesity (285)
Opinion (182)
Ovarian cancer (74)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (153)
Partnered (20)
Patents (181)
Patient recruitment (113)
Peanut (45)
People (48286)
Pharmaceutical (45)
Pharmacy benefit managers (10)
Phase I (21321)
Phase II (29571)
Phase III (21488)
Pipeline (1144)
Policy (107)
Postmarket research (2155)
Preclinical (7901)
Press Release (67)
Prostate cancer (103)
Psychedelics (33)
Radiopharmaceuticals (259)
Rare diseases (365)
Real estate (4818)
Recruiting (39)
Regulatory (19252)
Reports (27)
Research institute (2112)
Resumes & cover letters (224)
Rett syndrome (5)
RNA editing (4)
RSV (27)
Schizophrenia (69)
Series A (128)
Series B (87)
Service/supplier (17)
Sickle cell disease (50)
Special edition (15)
Spinal muscular atrophy (145)
Sponsored (28)
Startups (2954)
State (2)
Stomach cancer (12)
Supply chain (54)
Tariffs (18)
The Weekly (20)
Vaccines (552)
Venture capitalists (26)
Weight loss (162)
Women's health (34)
Worklife (12)
Date
Today (177)
Last 7 days (802)
Last 30 days (2401)
Last 365 days (30543)
2025 (9972)
2024 (32703)
2023 (37187)
2022 (47504)
2021 (50973)
2020 (49040)
2019 (41813)
2018 (31553)
2017 (28515)
2016 (26620)
2015 (31156)
2014 (23242)
2013 (18389)
2012 (19595)
2011 (20475)
2010 (18730)
Location
Africa (569)
Alabama (49)
Alaska (6)
Arizona (154)
Arkansas (11)
Asia (38851)
Australia (6392)
California (5637)
Canada (1835)
China (513)
Colorado (244)
Connecticut (265)
Delaware (137)
Europe (77555)
Florida (821)
Georgia (190)
Hawaii (1)
Idaho (48)
Illinois (449)
India (25)
Indiana (269)
Iowa (8)
Japan (156)
Kansas (88)
Kentucky (24)
Louisiana (9)
Maine (36)
Maryland (817)
Massachusetts (4254)
Michigan (182)
Minnesota (313)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (20)
Nevada (59)
New Hampshire (58)
New Jersey (1555)
New Mexico (25)
New York (1631)
North Carolina (963)
North Dakota (8)
Northern California (2488)
Ohio (193)
Oklahoma (13)
Oregon (31)
Pennsylvania (1253)
Puerto Rico (13)
Rhode Island (26)
South America (837)
South Carolina (16)
South Dakota (1)
Southern California (2134)
Tennessee (88)
Texas (868)
United States (21182)
Utah (153)
Virginia (137)
Washington D.C. (51)
Washington State (501)
West Virginia (3)
Wisconsin (49)
571,000 Results for "clinical network services cns pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
May 1, 2025
·
5 min read
Press Releases
Butterfly Network to Participate at Oppenheimer 35th Annual Healthcare MedTech & Services Virtual Conference on March 18, 2025
March 5, 2025
·
2 min read
Press Releases
New Data to Be Presented at Upcoming Congresses Showcase Cerevance’s Advanced Clinical Program in Parkinson’s Disease and Deep Pipeline for CNS-based Disorders
March 28, 2025
·
2 min read
Avance Clinical Expands Specialist CNS, Cardiometabolic, and Rare Diseases CRO Services in Europe with Julius Clinical
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS
June 3, 2024
·
3 min read
Press Releases
Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer
April 1, 2025
·
2 min read
Press Releases
Trial Library and American Oncology Network Partner to Expand Patient Access to Cancer Clinical Trials
March 12, 2025
·
3 min read
Business
RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services
RespireRx Pharmaceuticals Inc. are pleased to announce that on October 9, 2023, ResolutionRx entered into a Master Services Agreement (“MSA”) with Ab Initio Pharma Pty Ltd.
October 12, 2023
·
13 min read
1 of 57,100
Next
